USPTO serial 79144590
GEMINI PHARMCHEM
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- FALK, JONATHAN ROBERT
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GEMINI PHARMCHEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rachel Rudensky
RACHEL RUDENSKY AKERMAN LLP777 SOUTH FLAGLER DRIVESUITE 1100 WEST TOWERWEST PALM BEACH, FL 33401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CHEMICALS FOR USE IN INDUSTRY AND SCIENCE, NAMELY, CHEMICAL PREPARATIONS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS, ACTIVE PHARMACEUTICAL INGREDIENTS FOR THE MANUFACTURE OF FINISHED PHARMACEUTICALS, ACTIVE CHEMICAL INGREDIENTS AND AGENTS FOR USE IN THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS, PHARMACEUTICALS, ANTIPARASITICS AND ANTIPARASITIC PREPARATIONS; PRESERVATIVES FOR PHARMACEUTICAL PREPARATIONS | ABANDONED | — |
| 005 | PHARMACEUTICAL AND VETERINARY PREPARATIONS FOR TREATING VARIOUS TYPES OF CANCERS, DISEASES OF THE IMMUNOLOGICAL SYSTEM, NAMELY, AUTO-IMMUNE DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, AND FOR PREVENTION OF ORGAN REJECTION AFTER TRANSPLANTATION, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; CHEMICAL PREPARATIONS FOR PHARMACEUTICAL USE, NAMELY, FOR TREATING CANCER AND ONCOLOGY DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; CHEMICAL REAGENTS FOR MEDICAL OR VETERINARY USE; PHARMACEUTICAL PREPARATIONS FOR MEDICAL USE FOR TREATING CANCER AND ONCOLOGY DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY; ANTIBIOTICS; DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS; RADIOACTIVE SUBSTANCES FOR USE IN NUCLEAR MEDICINE; ANTIPARASITICS AND ANTIPARASITIC PREPARATIONS | ABANDONED | — |
| 035 | BUSINESS MANAGEMENT SERVICES, NAMELY, REGULATORY SUBMISSION MANAGEMENT, NAMELY, ASSISTING OTHERS IN PREPARING AND FILING APPLICATIONS FOR DRUGS WITH GOVERNMENTAL REGULATORY BODIES; RETAIL SERVICES, NAMELY, RETAIL STORE SERVICES, MAIL ORDER SERVICES AND ON-LINE RETAIL STORE SERVICES FEATURING ACTIVE PHARMACEUTICAL INGREDIENTS, AND VETERINARY PREPARATIONS, CHEMICAL PREPARATIONS FOR PHARMACEUTICAL PURPOSES, PHARMACEUTICAL PREPARATIONS FOR MEDICAL PURPOSES, DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS, RADIOACTIVE SUBSTANCES FOR USE IN NUCLEAR MEDICINE, all of the aforementioned services only in relation to pharmaceuticals and chemicals | ABANDONED | — |
| 042 | scientific and technological services, namely, research, design, evaluations and engineering appraisals in the fields of chemical intermediates, active chemical ingredients provided by engineers and scientists; industrial analysis and research services in the field of chemical intermediates and active chemical ingredients; engineering; research in the field of chemical research; chemical analysis; chemistry services, namely, chemistry consultation, research in the field of chemistry, optimization of chemical processes, analysis for polymorphism determination; biological research; bacteriological research; physics research; chemical research, all of the aforementioned services only in relation to pharmaceuticals and chemicals | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gemini PharmChem Mannheim GmbH
- Other trademarks owned by Gemini PharmChem Mannheim GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named GEMINI PHARMCHEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 23, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 31, 2018 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 3, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 3, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 3, 2017 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Aug 3, 2017 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Aug 3, 2017 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 3, 2017 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Mar 16, 2016 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Dec 18, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 17, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 22, 2015 | IRRF | IRREGULARITY ON REFUSAL FROM IB | — |
| Oct 19, 2015 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Oct 16, 2015 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Oct 16, 2015 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Sep 25, 2015 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 9, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 9, 2015 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 23, 2015 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 23, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 23, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 3, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 3, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 3, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 19, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 8, 2015 | EXPT | EXPARTE APPEAL TERMINATED | — |
| May 8, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 22, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2015 | ALIE | ASSIGNED TO LIE | — |
| Apr 20, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 20, 2015 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 20, 2015 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 20, 2015 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Oct 21, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 21, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 21, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 30, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 25, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 9, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 9, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 9, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 8, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 4, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 4, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |